BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136205 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Zhangjun Liao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dong…. Hauptthemen laut MEDLINE: Glioma, Antigens, CD, GPI-Linked Proteins, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Key Discipline Construction Project of Guangdong Medical University, National Undergraduate Training Program for Innovation and Entrepreneurship.
Abstract (Originalsprache)
High-grade gliomas (HGGs, WHO grades 3–4) are highly aggressive, with a poor prognosis and treatment resistance. Immune evasion may contribute to their progression, but the role of cytotoxic T-lymphocyte immune evasion (CTLE) is not well-validated. This study analyzed the transcriptomic data of 525 patients from TCGA-GBM-HG_U133A. Two molecular subtypes were identified based on 182 CTLE-associated genes, with 238 differentially expressed genes between them. A prognostic model was developed, identifying BST2 and DIRAS3 as key risk factors, and validated in multiple cohorts. The subtypes had distinct immune profiles, with Cluster 2 showing higher immune infiltration but a poorer prognosis. The model had a good predictive performance. High-risk patients had upregulated BST2 and DIRAS3, linked to immunosuppression and shorter survival. Knockdown experiments confirmed their roles in GBM cell migration and invasion. Mechanistically, they promote immune evasion. BST2 and DIRAS3 could be therapeutic targets for HGG immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, School of Medical Technology, Guangdong Medical University, Dongguan 523808, China.
ORCID-Profile: Shuyi Wu
Förderung
- Natural Science Foundation of Guangdong Province
- Key Discipline Construction Project of Guangdong Medical University
- National Undergraduate Training Program for Innovation and Entrepreneurship
Zitieren
APA
Liao, Z., Wu, S., Shi, Z., Chen, D., Chen, J., & Zhang, H. (2025). BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136205
Vancouver
Liao Z, Wu S, Shi Z, Chen D, Chen J, Zhang H. BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136205
BibTeX
@article{Liao2025,
author = {Liao, Zhangjun and Wu, Shuyi and Shi, Zhenyi and Chen, Donghui and Chen, Jinrui and Zhang, Hua},
title = {BST2 and DIRAS3 Drive Immune Evasion and Tumor Progression in High-Grade Glioma},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136205}
}
EUVIMED